Most recent SEC Form 4 filing date in this data: 2026-10-28. Source: SEC EDGAR.
This page lists insider trading activity reported for Xbiotech Inc. (XBIT). InsiderCompass processes every SEC Form 4 filing by Xbiotech Inc. executives, directors, and 10% beneficial owners to list discretionary open-market purchases (transaction code P).
InsiderCompass monitors all SEC Form 4 insider trading filings for Xbiotech Inc. (XBIT). Each transaction is classified as a discretionary transaction or as routine equity compensation activity. Discretionary open-market purchases are classified separately from option exercises and planned 10b5-1 sales.
InsiderCompass processes SEC Form 4 filings daily to track insider trading activity. Each transaction is classified as discretionary or non-discretionary based on transaction codes, footnote analysis, and 10b5-1 plan indicators. Transaction code P marks a purchase; a purchase the filing reports as made under a 10b5-1 plan is classified as non-discretionary.
InsiderCompass groups purchases by two or more insiders at the same company within a seven-day sliding window, with a combined value of at least $50,000, as a multi-insider purchase.
View the latest insider buying activity for Xbiotech Inc. (XBIT) including Form 4 filings, purchase amounts, and insider names on InsiderCompass.
InsiderCompass tracks all Form 4 insider transactions for Xbiotech Inc. including open-market purchases, sales, option exercises, and multi-insider purchases.
XBIT Form 4 filings show insider purchases and sales by executives, directors, and 10% owners. InsiderCompass reports these filings and the resulting change in each insider’s holdings.
Loading insider trading data...